| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
a INSERM U407, Centre Hospitalier Lyon-Sud, 69495 Pierre-Bénite cédex, France
b Laboratoire d'Hématologie, Centre Hospitalier universitaire, La Tronche, BP 217, 38043 Grenoble cédex 9, France
Sertoli cells secrete plasminogen activators (PAs) on both sides of the blood-testis barrier, i.e., in the basal and apical compartments of the seminiferous tubules, whereas peritubular cells secrete plasminogen activator inhibitor-1 (PAI-1), a fast-acting and specific PA inhibitor. While it is likely that PAI-1 produced by peritubular cells counteracts the basal secretion of PA, the nature of the PA inhibitor acting in the apical compartment remains to be demonstrated. In the present study, we showed that Sertoli cells recovered from 20-day-old rats and cultured contained a transcript of 3–3.2 kilobases, which hybridized specifically to a PAI-1 cDNA probe (Northern blot). We verified that the observed PAI-1 transcript could not result solely from the peritubular cells (weakly contaminating the Sertoli cell cultures), by comparing PAI-1 mRNA levels of Sertoli and peritubular cells recovered from 20-day-old rats and cultured. We also demonstrated that cultured Sertoli cells secreted a protein that complexed with tissue-type PA (zymography), indicating that it was biologically active. This protein comigrated with purified PAI-1 as a doublet of 46 and 49 kDa (Western blot). The trophic hormone FSH decreased PAI-1 messenger RNA as well as immunoreactive PAI-1 protein (probably via the cAMP protein kinase A pathway), whereas transforming growth factor ß1 and basic fibroblast growth factor (in a nanomolar concentration) increased both of these. These observations support the hypothesis that PAI-1 is expressed by Sertoli cells and is under a complex hormonal (FSH) and paracrine and/or autocrine control exerted at least by basic fibroblast growth factor and transforming growth factor ß1.
2 Correspondence: Brigitte Le Magueresse-Battistoni, INSERM U407, Batiment 3B, Centre Hospitalier Lyon-sud, 69495 Pierre-Bénite cédex, France. FAX: (33) 478865922; magueress{at}lsgrisn1.univ-lyon.1.fr
This article has been cited by other articles:
|
|
 |
|
  S. Mazaud Guittot, A. Verot, F. Odet, M.-A. Chauvin, and B. le Magueresse-Battistoni A comprehensive survey of the laminins and collagens type IV expressed in mouse Leydig cells and their regulation by LH/hCG Reproduction, April 1, 2008; 135(4): 479 - 488. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Le Magueresse-Battistoni Serine proteases and serine protease inhibitors in testicular physiology: the plasminogen activation system Reproduction, December 1, 2007; 134(6): 721 - 729. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P Froment, M Vigier, D Negre, I Fontaine, J Beghelli, F L Cosset, M Holzenberger, and P Durand Inactivation of the IGF-I receptor gene in primary Sertoli cells highlights the autocrine effects of IGF-I J. Endocrinol., September 1, 2007; 194(3): 557 - 568. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Odet, A. Verot, and B. Le Magueresse-Battistoni The Mouse Testis Is the Source of Various Serine Proteases and Serine Proteinase Inhibitors (SERPINs): Serine Proteases and SERPINs Identified in Leydig Cells Are under Gonadotropin Regulation Endocrinology, September 1, 2006; 147(9): 4374 - 4383. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R E. Ramy, A Verot, S Mazaud, F Odet, S Magre, and B Le Magueresse-Battistoni Fibroblast growth factor (FGF) 2 and FGF9 mediate mesenchymal-epithelial interactions of peritubular and Sertoli cells in the rat testis J. Endocrinol., October 1, 2005; 187(1): 135 - 147. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. D. Mruk and C. Y. Cheng Sertoli-Sertoli and Sertoli-Germ Cell Interactions and Their Significance in Germ Cell Movement in the Seminiferous Epithelium during Spermatogenesis Endocr. Rev., October 1, 2004; 25(5): 747 - 806. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Odet, R. Guyot, P. Leduque, and B. Le Magueresse-Battistoni Evidence for Similar Expression of Protein C Inhibitor and the Urokinase-Type Plasminogen Activator System during Mouse Testis Development Endocrinology, March 1, 2004; 145(3): 1481 - 1489. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. D. Anway, J. Folmer, W. W. Wright, and B. R. Zirkin Isolation of Sertoli Cells from Adult Rat Testes: An Approach to Ex Vivo Studies of Sertoli Cell Function Biol Reprod, March 1, 2003; 68(3): 996 - 1002. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W.-Y. Lui, W. M. Lee, and C. Y. Cheng Transforming Growth Factor-{beta}3 Perturbs the Inter-Sertoli Tight Junction Permeability Barrier in Vitro Possibly Mediated via Its Effects on Occludin, Zonula Occludens-1, and Claudin-11 Endocrinology, May 1, 2001; 142(5): 1865 - 1877. [Abstract] [Full Text]
|
|
|
|
 |
|
 J. Longin, P. Guillaumot, M.-A. Chauvin, A.-M. Morera, and B. Le Magueresse-Battistoni MT1-MMP in rat testicular development and the control of Sertoli cell proMMP-2 activation J. Cell Sci., January 6, 2001; 114(11): 2125 - 2134. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Canipari and M. Galdieri Retinoid Modulation of Plasminogen Activator Production in Rat Sertoli Cells Biol Reprod, August 1, 2000; 63(2): 544 - 550. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
